Zhejiang Jiuzhou Pharmaceutical 483, Jan 2016

Zhejiang Jiuzhou Pharmaceutical 483, Jan 2016

Peter Baker FDA, Christopher Middendorf FDA$119.00

FDA investigators audited the Zhejiang Jiuzhou Pharmaceutical facility in Taizhou, China and issued inspectional observations (via FDA 483) on 23 Jan 2016.

Buy This DocumentBuy 1-Year 483 Access

Product details

  • Inspection end: 23 Jan 2016
  • Location: Taizhou, China